Epigenetic mechanisms in patients undergoing cardiac surgery
- Conditions
- R65.9R65.1R65.3Systemic Inflammatory Response Syndrome, unspecifiedSystemic Inflammatory Response Syndrome of infectious origin with organ failureSystemic Inflammatory Response Syndrome of non-infectious origin with organ failure
- Registration Number
- DRKS00032718
- Lead Sponsor
- niversitätsklinikum Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
1.) Age >18 years
2.) Elective cardiac surgery patients with planned use of a heart-lung machine
3.) written declaration of consent
Exclusion Criteria
1.) Age <18 years
2.) Immunosuppressive long-term medication
3.) no declaration of consent available
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analysis of the influence of epigenetic mechanisms on the level of cell regulation using blood samples, epigenetic studies and PCR
- Secondary Outcome Measures
Name Time Method no entry
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What epigenetic modifications are linked to SIRS progression in cardiac surgery patients with organ failure?
How do histone deacetylase (HDAC) inhibitors compare to standard anti-inflammatory therapies in managing post-cardiac surgery SIRS?
Which DNA methylation biomarkers predict severity of non-infectious SIRS after open-heart procedures?
What adverse events are associated with epigenetic dysregulation in R65.3 SIRS patients undergoing cardiopulmonary bypass?
Are there synergistic epigenetic-drug combinations for treating R65.1 infectious SIRS with multi-organ dysfunction post-surgery?